Breaking News, Trials & Filings

Trials & Filings: Oct. 21, 2013

GSK, Genmab, Keryx, Iroko, Ganymed

Filings
GSK, Genmab submit sBLA for Arzerra in CLL… read more

Keryx assigned PDUFA date for Zerenex… read more

FDA approves Iroko’s Zorvolex… read more

Ganymed’s IMAB362 receives Orphan Designation… read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters